NeoGenomics Reports Record Revenue of $76 Million with 17% Organic Revenue Growth in the Fourth Quarter
February 19, 2019 07:00 ET
|
NeoGenomics, Inc.
FT. MYERS, Fla., Feb. 19, 2019 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the fourth quarter...
NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2018 Earnings Release for February 19, 2019
January 28, 2019 07:00 ET
|
NeoGenomics, Inc.
FT. MYERS, Fla., Jan. 28, 2019 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it plans to release its fourth...
NeoGenomics Appoints Dr. Lawrence M. Weiss as Chief Scientific Officer
December 13, 2018 07:00 ET
|
NeoGenomics, Inc.
FT. MYERS, Fla., Dec. 13, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced the appointment of Lawrence M....
NeoGenomics Announces Pricing on Secondary Offering of Common Stock by Selling Stockholder
December 12, 2018 07:35 ET
|
NeoGenomics, Inc.
FT. MYERS, Fla., Dec. 12, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced the pricing of an underwritten...
NeoGenomics Announces Secondary Offering of Common Stock by Selling Stockholder
December 11, 2018 16:10 ET
|
NeoGenomics, Inc.
FORT MYERS, Fla., Dec. 11, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced that GE Medical Systems...
NeoGenomics Completes Acquisition of Genoptix, Inc.
December 10, 2018 09:10 ET
|
NeoGenomics, Inc.
FT. MYERS, Fla., Dec. 10, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has completed the...
QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugs
November 30, 2018 17:01 ET
|
NeoGenomics, Inc.
Partners discuss efforts to accelerate precision medicine solutions at ASH 2018 HILDEN, Germany and GERMANTOWN, Md. and FORT MYERS, Fla., Nov. 30, 2018 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN;...
NeoGenomics Reports 17% Revenue Growth to Record $69 Million
October 30, 2018 07:00 ET
|
NeoGenomics, Inc.
FT. MYERS, Fla., Oct. 30, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the third quarter of...
NeoGenomics Signs Definitive Agreement to Acquire Genoptix
October 23, 2018 07:00 ET
|
NeoGenomics, Inc.
FT. MYERS, Fla., Oct. 23, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has entered into a...
NeoGenomics Schedules its Third Quarter Earnings Release for October 30, 2018
October 01, 2018 07:00 ET
|
NeoGenomics, Inc.
FT. MYERS, Fla., Oct. 01, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it plans to release its third...